• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗氧化剂减少肝细胞脂肪堆积的作用。

Effects of Antioxidants in Reducing Accumulation of Fat in Hepatocyte.

机构信息

Department of Parasitology and Tropical Medicine, Seoul National University College of Medicine, and Institute of Endemic Diseases, Seoul 03080, Korea.

Department of Neurosurgery, Seoul National University College of Medicine, SMG-SNU Boramae Medical Center, Seoul 07061, Korea.

出版信息

Int J Mol Sci. 2018 Aug 29;19(9):2563. doi: 10.3390/ijms19092563.

DOI:10.3390/ijms19092563
PMID:30158441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6164327/
Abstract

The progress of the hepatic steatosis (HS), a clinicopathological status, is influenced by cellular oxidative stress, lipogenesis, fatty acid (FA) oxidation, and inflammatory responses. Because antioxidants are gaining attention as potent preventive agents for HS, we aimed to investigate anti-lipogenic effects of the antioxidants vitamin C (VC), N-acetylcysteine (NAC), and astaxanthin (ATX) using hepatocytes. For this, we established an in vitro model using 1 mM oleic acid (OA) and human liver hepatocellular carcinoma (HepG2) cells; 10 μM antioxidants were evaluated for their ability to reduce fat accumulation in hepatocytes. Our results showed that all three antioxidants were effective to reduce fat accumulation for the molecular targets such as reduction in lipid droplets, triglyceride (TG) concentration, reactive oxygen species (ROS) production, and cell apoptosis, as well as in gene expressions of endoplasmic reticulum (ER) stress-related effectors, lipogenesis, and inflammatory cytokines. There were simultaneous increases in diphenyl-1-picrylhydrazyl (DPPH) radical scavenging effect, cell survival, AMPK phosphorylation, NRF2-related gene expression for cellular defense, and FA β-oxidation. However, among these, ATX more effectively inhibited ER stress and lipogenesis at the intracellular level than VC or NAC. Consequently, ATX was also more effective in inhibiting cell death, lipotoxicity, and inflammation. Our result emphasizes that ATX achieved greater lipotoxicity reduction than VC and NAC.

摘要

肝脂肪变性(HS)的进展是一个临床病理状态,受细胞氧化应激、脂肪生成、脂肪酸(FA)氧化和炎症反应的影响。由于抗氧化剂作为 HS 的有效预防剂越来越受到关注,我们旨在使用肝细胞研究抗氧化剂维生素 C(VC)、N-乙酰半胱氨酸(NAC)和虾青素(ATX)的抗脂肪生成作用。为此,我们使用 1mM 油酸(OA)和人肝癌细胞(HepG2)建立了体外模型;评估了 10μM 抗氧化剂减少肝细胞脂肪积累的能力。我们的结果表明,所有三种抗氧化剂都能有效减少脂肪积累,其分子靶标包括减少脂滴、甘油三酯(TG)浓度、活性氧(ROS)产生和细胞凋亡,以及内质网(ER)应激相关效应物、脂肪生成和炎症细胞因子的基因表达。同时,二苯基-1-苦基肼(DPPH)自由基清除作用、细胞存活、AMPK 磷酸化、细胞防御相关的 NRF2 相关基因表达和 FA β-氧化增加。然而,在这些抗氧化剂中,ATX 比 VC 或 NAC 更有效地抑制细胞内 ER 应激和脂肪生成。因此,ATX 在抑制细胞死亡、脂毒性和炎症方面也更有效。我们的结果强调,ATX 比 VC 和 NAC 更能有效降低脂毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/95047bb346e1/ijms-19-02563-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/a8fea22995fb/ijms-19-02563-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/7b5bee894cfc/ijms-19-02563-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/f5d2ffca564f/ijms-19-02563-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/7261e4bd3e77/ijms-19-02563-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/083aaf4ee35d/ijms-19-02563-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/91e34ec59f3d/ijms-19-02563-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/8a24650ff6b7/ijms-19-02563-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/268aebedc6b5/ijms-19-02563-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/2e08b7a1b5ee/ijms-19-02563-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/95047bb346e1/ijms-19-02563-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/a8fea22995fb/ijms-19-02563-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/7b5bee894cfc/ijms-19-02563-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/f5d2ffca564f/ijms-19-02563-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/7261e4bd3e77/ijms-19-02563-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/083aaf4ee35d/ijms-19-02563-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/91e34ec59f3d/ijms-19-02563-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/8a24650ff6b7/ijms-19-02563-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/268aebedc6b5/ijms-19-02563-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/2e08b7a1b5ee/ijms-19-02563-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29fe/6164327/95047bb346e1/ijms-19-02563-g010.jpg

相似文献

1
Effects of Antioxidants in Reducing Accumulation of Fat in Hepatocyte.抗氧化剂减少肝细胞脂肪堆积的作用。
Int J Mol Sci. 2018 Aug 29;19(9):2563. doi: 10.3390/ijms19092563.
2
Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes.软脂酸诱导的线粒体代谢激活促进 H4IIEC3 大鼠肝细胞的氧化应激和细胞凋亡。
Metabolism. 2014 Feb;63(2):283-95. doi: 10.1016/j.metabol.2013.10.009. Epub 2013 Oct 24.
3
Silybin counteracts lipid excess and oxidative stress in cultured steatotic hepatic cells.水飞蓟宾可对抗培养的脂肪变性肝细胞中的脂质过量和氧化应激。
World J Gastroenterol. 2016 Jul 14;22(26):6016-26. doi: 10.3748/wjg.v22.i26.6016.
4
N-acetylcysteine attenuates reactive-oxygen-species-mediated endoplasmic reticulum stress during liver ischemia-reperfusion injury.N-乙酰半胱氨酸减轻肝脏缺血再灌注损伤期间活性氧介导的内质网应激。
World J Gastroenterol. 2014 Nov 7;20(41):15289-98. doi: 10.3748/wjg.v20.i41.15289.
5
Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis.獐芽菜苦苷通过抑制肝脂肪变性中的糖异生和脂质生成来改善油酸诱导的脂质积累和氧化应激。
Biomed Pharmacother. 2016 Oct;83:785-791. doi: 10.1016/j.biopha.2016.07.028. Epub 2016 Aug 1.
6
Enhanced endoplasmic reticulum SERCA activity by overexpression of hepatic stimulator substance gene prevents hepatic cells from ER stress-induced apoptosis.过表达肝刺激物质基因增强内质网 SERCA 活性可防止肝细胞发生内质网应激诱导的细胞凋亡。
Am J Physiol Cell Physiol. 2014 Feb 1;306(3):C279-90. doi: 10.1152/ajpcell.00117.2013. Epub 2013 Nov 27.
7
Wolf Extract Ameliorates Hepatic Steatosis through Regulation of Lipid Metabolism, Inhibition of ER Stress, and Activation of Autophagy via AMPK Activation.狼提取物通过激活 AMPK 来调节脂质代谢、抑制内质网应激和激活自噬,从而改善肝脂肪变性。
Int J Mol Sci. 2019 Sep 27;20(19):4801. doi: 10.3390/ijms20194801.
8
Scopoletin and umbelliferone protect hepatocytes against palmitate- and bile acid-induced cell death by reducing endoplasmic reticulum stress and oxidative stress.东莨菪亭和伞形酮通过减轻内质网应激和氧化应激来保护肝细胞免受棕榈酸酯和胆汁酸诱导的细胞死亡。
Toxicol Appl Pharmacol. 2022 Feb 1;436:115858. doi: 10.1016/j.taap.2021.115858. Epub 2021 Dec 31.
9
Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis.油酸可保护肝细胞及非酒精性脂肪性肝炎大鼠中饱和脂肪酸介导的脂毒性。
Life Sci. 2018 Jun 15;203:291-304. doi: 10.1016/j.lfs.2018.04.022. Epub 2018 Apr 27.
10
Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.厚朴酚激活LKB1-AMPK信号通路并减轻肝细胞中的脂质积累。
Toxicol Appl Pharmacol. 2015 Apr 15;284(2):113-24. doi: 10.1016/j.taap.2015.02.020. Epub 2015 Feb 28.

引用本文的文献

1
Novel mechanism for tubular injury in nephropathic cystinosis.肾病性胱氨酸病肾小管损伤的新机制。
Elife. 2025 Mar 20;13:RP94169. doi: 10.7554/eLife.94169.
2
Coffee Compounds Protection Against Lipotoxicity Is Associated with Lipid Droplet Formation and Antioxidant Response in Primary Rat Hepatocytes.咖啡化合物对脂毒性的保护作用与原代大鼠肝细胞中脂滴形成及抗氧化反应有关。
Antioxidants (Basel). 2025 Jan 31;14(2):175. doi: 10.3390/antiox14020175.
3
Potential of natural drug modulation of endoplasmic reticulum stress in the treatment of myocardial injury.

本文引用的文献

1
Food components with antifibrotic activity and implications in prevention of liver disease.具有抗纤维化活性的食物成分及其在预防肝病中的意义。
J Nutr Biochem. 2018 May;55:1-11. doi: 10.1016/j.jnutbio.2017.11.003. Epub 2017 Nov 16.
2
Polyphenols Treatment in Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者的多酚类物质治疗
J Transl Int Med. 2017 Sep 30;5(3):144-147. doi: 10.1515/jtim-2017-0027. eCollection 2017 Sep.
3
A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease.
天然药物调节内质网应激在心肌损伤治疗中的潜力。
J Pharm Anal. 2024 Nov;14(11):101034. doi: 10.1016/j.jpha.2024.101034. Epub 2024 Jul 2.
4
Efect of N-acetylcysteine on HepG2 cells which were induced into fatty liver cells.N-乙酰半胱氨酸对诱导为脂肪肝细胞的HepG2细胞的影响。
J Mol Histol. 2024 Dec 4;56(1):27. doi: 10.1007/s10735-024-10313-2.
5
A new opportunity for N-acetylcysteine. An outline of its classic antioxidant effects and its pharmacological potential as an epigenetic modulator in liver diseases treatment.N-乙酰半胱氨酸的新机遇。概述其经典抗氧化作用及其作为表观遗传调节剂在肝病治疗中的药理潜力。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2365-2386. doi: 10.1007/s00210-024-03539-0. Epub 2024 Oct 22.
6
Growth, Antioxidant Capacity, and Liver Health in Largemouth Bass () Fed Multi-Strain Yeast-Based Paraprobiotic: A Lab-to-Pilot Scale Evaluation.投喂基于多菌株酵母的副益生菌的大口黑鲈()的生长、抗氧化能力和肝脏健康:从实验室规模到中试规模的评估
Antioxidants (Basel). 2024 Jun 28;13(7):792. doi: 10.3390/antiox13070792.
7
Astaxanthin Ameliorates Worsened Muscle Dysfunction of MDX Mice Fed with a High-Fat Diet through Reducing Lipotoxicity and Regulating Gut Microbiota.虾青素通过降低脂毒性和调节肠道微生物群改善高脂肪饮食喂养的 MDX 小鼠的肌肉功能障碍。
Nutrients. 2023 Dec 21;16(1):33. doi: 10.3390/nu16010033.
8
Astaxanthin: Past, Present, and Future.虾青素:过去、现在和未来。
Mar Drugs. 2023 Sep 28;21(10):514. doi: 10.3390/md21100514.
9
Lactobacillus plantarum improves LPS-induced Caco2 cell line intestinal barrier damage via cyclic AMP-PKA signaling.植物乳杆菌通过环 AMP-PKA 信号通路改善脂多糖诱导的 Caco2 细胞系肠道屏障损伤。
PLoS One. 2022 May 31;17(5):e0267831. doi: 10.1371/journal.pone.0267831. eCollection 2022.
10
Evaluation of Bioactive Metabolites and Antioxidant-Rich Extracts of Amaranths with Possible Role in Pancreatic Lipase Interaction: In Silico and In Vitro Studies.苋属植物生物活性代谢产物及富含抗氧化剂提取物对胰脂肪酶相互作用的潜在作用评估:计算机模拟和体外研究
Metabolites. 2021 Sep 30;11(10):676. doi: 10.3390/metabo11100676.
非酒精性脂肪性肝病中胰岛素抵抗和炎症之间的恶性循环。
Lipids Health Dis. 2017 Oct 16;16(1):203. doi: 10.1186/s12944-017-0572-9.
4
The Potential of Non-Provitamin A Carotenoids for the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease.非维生素A类胡萝卜素在预防和治疗非酒精性脂肪性肝病中的潜力
Biology (Basel). 2016 Nov 8;5(4):42. doi: 10.3390/biology5040042.
5
Astaxanthin as a Potential Protector of Liver Function: A Review.虾青素作为肝功能潜在保护剂的综述
J Clin Med Res. 2016 Oct;8(10):701-4. doi: 10.14740/jocmr2672w. Epub 2016 Aug 30.
6
Metabolic aspects of adult patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病成年患者的代谢方面
World J Gastroenterol. 2016 Aug 21;22(31):7006-16. doi: 10.3748/wjg.v22.i31.7006.
7
Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease.微量营养素抗氧化剂与非酒精性脂肪性肝病
Int J Mol Sci. 2016 Aug 23;17(9):1379. doi: 10.3390/ijms17091379.
8
The Role of Vitamins in the Pathogenesis of Non-alcoholic Fatty Liver Disease.维生素在非酒精性脂肪性肝病发病机制中的作用
Integr Med Insights. 2016 Apr 27;11:19-25. doi: 10.4137/IMI.S31451. eCollection 2016.
9
Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine.肝脏疾病中的氧化应激与炎症:N-乙酰半胱氨酸的治疗潜力
Int J Mol Sci. 2015 Dec 18;16(12):30269-308. doi: 10.3390/ijms161226225.
10
Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats.熊去氧胆酸、白藜芦醇和N-乙酰半胱氨酸对大鼠非酒精性脂肪性肝病的保护作用
Pharm Biol. 2016 Jul;54(7):1198-208. doi: 10.3109/13880209.2015.1060247. Epub 2015 Jul 1.